227 related articles for article (PubMed ID: 21934619)
1. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
Eslam M; López-Cortés LF; Romero-Gomez M
Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
[TBL] [Abstract][Full Text] [Related]
2. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
[TBL] [Abstract][Full Text] [Related]
3. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
Deming P; McNicholl IR
Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
[TBL] [Abstract][Full Text] [Related]
4. HIV and hepatitis C virus coinfection: bad bedfellows.
Schooley RT
Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
Verucchi G; Calza L; Manfredi R; Chiodo F
Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
[TBL] [Abstract][Full Text] [Related]
7. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C virus coinfection in HIV-infected persons.
O'Leary JG; Chung RT
AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study.
Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Pol S; Halfon P
Antivir Ther; 2009; 14(6):839-45. PubMed ID: 19812446
[TBL] [Abstract][Full Text] [Related]
10. Therapy of hepatitis C in HIV-coinfection.
Rockstroh JK; Vogel M
Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
[TBL] [Abstract][Full Text] [Related]
11. Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients.
Ballesteros AL; Fuster D; Planas R; Clotet B; Tural C
J Antimicrob Chemother; 2005 Jun; 55(6):824-7. PubMed ID: 15886264
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatitis C virus/HIV coinfection.
Chun S; Sherman KE
Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
[TBL] [Abstract][Full Text] [Related]
13. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
[TBL] [Abstract][Full Text] [Related]
14. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
15. HIV and hepatitis C co-infection: acute HCV therapy.
Boesecke C; Vogel M
Curr Opin HIV AIDS; 2011 Nov; 6(6):459-64. PubMed ID: 22001891
[TBL] [Abstract][Full Text] [Related]
16. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
Berenguer J; Fernandez-Rodríguez A; Jimenez-Sousa MA; Cosín J; Zarate P; Micheloud D; López JC; Miralles P; Catalán P; Resino S
Cytokine; 2012 Jan; 57(1):25-9. PubMed ID: 22136974
[TBL] [Abstract][Full Text] [Related]
17. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
Spengler U
Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
[TBL] [Abstract][Full Text] [Related]
18. Viral hepatitis and HIV: update and management.
Núñez M; Mendes-Correa MC
Antivir Ther; 2013; 18(3 Pt B):451-8. PubMed ID: 23792670
[TBL] [Abstract][Full Text] [Related]
19. Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.
Martel-Laferrière V; Brinkley S; Bichoupan K; Posner S; Stivala A; Perumalswami P; Schiano T; Sulkowski M; Dieterich D; Branch A
HIV Med; 2014 Feb; 15(2):108-15. PubMed ID: 24025147
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
Sterling RK; Sulkowski MS
Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]